Literature DB >> 11170287

Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma.

J M Fang1, M F Arlt, A C Burgess, S L Dagenais, D G Beer, T W Glover.   

Abstract

Common fragile sites have been proposed to play a mechanistic role in chromosome translocations and other rearrangements in cancer cells in vivo based on their behavior in vitro and their co-localization with cancer translocation breakpoints. This hypothesis has been the subject of controversy, because associations have been made at the chromosomal level and because of the large number of both fragile sites and cancer chromosome breakpoints. Tests of this hypothesis at the molecular level are now possible with the cloning of common fragile site loci and the use of fragile site clones in the analysis of rearranged chromosomes. FRA3B, the most frequently seen common fragile site, lies within the large FHIT gene. It is now well established that this region is the site of frequent, large intragenic deletions and aberrant transcripts in a number of tumors and tumor cell lines. In contrast, only one tumor-associated translocation involving the FHIT gene has been reported. We have found translocations in both homologs of chromosome 3 in an early-passage esophageal adenocarcinoma cell line. This cell line showed no normal FHIT transcripts by reverse transcription polymerase chain reaction. Subsequent chromosome analysis showed translocations of the short arms of both homologs of chromosome 3: t(3;16) and t(3;4). The breakpoints of both translocations were shown by fluorescence in situ hybridization and polymerase chain reaction to be in the FHIT gene, at or near the center of the fragile site region. Using rapid amplification of cDNA ends with FHIT primers, a noncoding chimeric transcript resulting from t(3;16) was identified. These data provide direct support for the hypothesis that FRA3B, and likely other common fragile sites, may be "hot spots" for translocations in certain cancers, as they are for deletions, and that such translocations have the potential to form abnormal chimeric transcripts. In addition, the results suggest selection for loss of a functional FHIT gene by the translocation events. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11170287     DOI: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1095>3.0.co;2-f

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  7 in total

1.  Deletion at fragile sites is a common and early event in Barrett's esophagus.

Authors:  Lisa A Lai; Rumen Kostadinov; Michael T Barrett; Daniel A Peiffer; Dimitry Pokholok; Robert Odze; Carissa A Sanchez; Carlo C Maley; Brian J Reid; Kevin L Gunderson; Peter S Rabinovitch
Journal:  Mol Cancer Res       Date:  2010-07-20       Impact factor: 5.852

2.  Homologous recombination and nonhomologous end-joining repair pathways regulate fragile site stability.

Authors:  Michal Schwartz; Eitan Zlotorynski; Michal Goldberg; Efrat Ozeri; Ayelet Rahat; Carlos le Sage; Benjamin P C Chen; David J Chen; Reuven Agami; Batsheva Kerem
Journal:  Genes Dev       Date:  2005-11-15       Impact factor: 11.361

3.  Conservation of aphidicolin-induced fragile sites in Papionini (Primates) species and humans.

Authors:  Aurora Ruiz-Herrera; Francisca Garcia; Lutz Frönicke; Montserrat Ponsà; Josep Egozcue; Montserrat Garcia Caldés; Roscoe Stanyon
Journal:  Chromosome Res       Date:  2004       Impact factor: 5.239

4.  Chromosome rearrangement associated inactivation of tumour suppressor genes in prostate cancer.

Authors:  Xueying Mao; Lara K Boyd; Rafael J Yáñez-Muñoz; Tracy Chaplin; Liyan Xue; Dongmei Lin; Ling Shan; Daniel M Berney; Bryan D Young; Yong-Jie Lu
Journal:  Am J Cancer Res       Date:  2011-04-15       Impact factor: 6.166

Review 5.  Common fragile site tumor suppressor genes and corresponding mouse models of cancer.

Authors:  Alessandra Drusco; Yuri Pekarsky; Stefan Costinean; Anna Antenucci; Laura Conti; Stefano Volinia; Rami I Aqeilan; Kay Huebner; Nicola Zanesi
Journal:  J Biomed Biotechnol       Date:  2010-12-29

6.  Analysis of the t(3;8) of hereditary renal cell carcinoma: a palindrome-mediated translocation.

Authors:  Takema Kato; Colleen P Franconi; Molly B Sheridan; April M Hacker; Hidehito Inagakai; Thomas W Glover; Martin F Arlt; Harry A Drabkin; Robert M Gemmill; Hiroki Kurahashi; Beverly S Emanuel
Journal:  Cancer Genet       Date:  2014-03-18

7.  A novel approach to simultaneously scan genes at fragile sites.

Authors:  Pascale Willem; Jacqueline Brown; Jan Schouten
Journal:  BMC Cancer       Date:  2006-08-08       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.